Plavsic Mark 4

What Happened
Mark Plavsic, Chief Technology Officer of Aura Biosciences (AURA), reported an automatic sale of 15,890 shares on February 17, 2026. The shares were disposed for a total of approximately $80,245 at a weighted average price of $5.05 per share (sales ranged from $5.04 to $5.24). This was a sale to satisfy tax withholding obligations related to the vesting of restricted stock units, not an elective open‑market trade.

Key Details

• Transaction date: 2026-02-17
• Transaction type/code: Sale (S); automatic sale to cover tax withholding on RSU vesting (Footnote F1)
• Shares sold: 15,890; Weighted average price: $5.05; Total proceeds: ~$80,245
• Reported price range: $5.04 to $5.24 across multiple trades (Footnote F2)
• Shares owned after transaction: Not disclosed in this Form 4
• Filing timeliness: Reported on the same date (no late filing indicated)

Context
Withholding sales tied to RSU vesting are routine and used to cover tax obligations; they generally do not signal the insider’s view on the company’s prospects. Purchases are typically more informative about insider confidence. Footnote F2 states the filer can provide per-trade breakdowns on request if investors or the SEC need the exact number of shares sold at each price.